EyeCatching Stock: Johnson & Johnson (JNJ)

Share

The firm has a market cap of $367.25 billion, a price-to-earnings ratio of 23.15 and a beta of 0.78. The Firm operates through two divisions: electric utility and natural gas midstream operations. It has a 19.97 P/E ratio. The electric utility segment generates, transmits, distributes and sells electric energy in Oklahoma and western Arkansas. Finally, Mountain Capital Investment Advisors Inc purchased a new stake in shares of Johnson & Johnson during the 2nd quarter valued at about $124,000. Wealth Architects Limited Co reported 0.29% in Johnson & Johnson (NYSE:JNJ). Johnson & Johnson now has $366.90 billion valuation. The Average Volume of the company is 5.25 Million, while the Volume of the company in the last trading session was 5.17 Billion. The stock of Home Depot Inc (NYSE:HD) has "Outperform" rating given on Monday, December 7 by Telsey Advisory Group. It has underperformed by 4.16% the S&P500.

Among 29 analysts covering The Home Depot Inc. 822.13 million shares or 1.82% less from 837.36 million shares in 2017Q1 were reported. The company reported $1.83 earnings per share for the quarter, topping analysts' consensus estimates of $1.79 by $0.04. About 1.54 million shares traded or 198.21% up from the average.

Investors sentiment increased to 1.85 in Q2 2017. Geode Capital Mgmt Ltd Liability Corp has invested 1.51% of its portfolio in Johnson & Johnson (NYSE:JNJ). The Massachusetts-based Telemark Asset Management Llc has invested 1.3% in the stock. 14,680 Home Depot Inc (NYSE:HD) shares with value of $2.30M were sold by Carey Matt. Roseborough Teresa Wynn sold 29,076 shares worth $4.57M. About 495,422 shares traded.

Analysts await Johnson & Johnson (NYSE:JNJ) to report earnings on October, 17 before the open. It has underperformed by 3.91% the S&P500.

A 6 analysts rate it as either a buy or a strong buy, while 0 believe that investors should either steer clear of (NYSE:CBG) or, if they already own its stock, sell it. Its up 0.12, from 0.83 in 2017Q1. It dived, as 50 investors sold JNJ shares while 878 reduced holdings. 120 funds opened positions while 517 raised stakes. Plante Moran Advisors Ltd Co invested in 0.46% or 4,760 shares.

Johnson & Johnson (NYSE:JNJ) last announced its quarterly earnings data on Tuesday, July 18th. Shares of CBG have increased 5.71% in the past three monthswhile the S&P 500 has gained 1.68% in that time. Hengehold Cap Mgmt Limited Company has invested 0.67% in Johnson & Johnson (NYSE:JNJ). Westwood Mngmt Il accumulated 4,850 shares. After a recent check, it is observed that the insiders for the firm now own 0.05% shares. Capital Mngmt Va holds 44,543 shares or 2.04% of its portfolio. Mcdaniel Terry invested in 4.66% or 181,806 shares. Motley Fool Wealth Ltd Limited Liability Company has 9,225 shares for 0.11% of their portfolio. 18,100 are owned by Legg Mason Asset Management (Japan).

The collective rating of 2.7 for Johnson & Johnson (NYSE:JNJ) also leans strongly towards the neutral end of the spectrum. Cannell Peter B Co Inc has invested 1.04% in Johnson & Johnson (NYSE:JNJ). Five analysts have rated the stock with a sell rating, eight have given a hold rating and ten have given a buy rating to the company. Therefore 52% are positive. Finally, Credit Suisse Group reissued a buy rating on shares of Johnson & Johnson in a report on Friday, August 4th. The company was reinitiated on Monday, October 5 by Piper Jaffray. Standpoint Research initiated Johnson & Johnson (NYSE:JNJ) on Friday, May 20 with "Sell" rating. On Friday, October 28 the stock rating was maintained by BMO Capital Markets with "Market Perform". The firm has "Buy" rating given on Wednesday, July 19 by UBS. Barclays Capital maintained it with "Overweight" rating and $120 target in Wednesday, April 20 report. The firm earned "Hold" rating on Monday, September 25 by Citigroup. The rating was maintained by RBC Capital Markets on Wednesday, July 20 with "Outperform". Vetr lowered Johnson & Johnson from a "hold" rating to a "sell" rating and set a $129.62 price objective for the company.in a report on Friday.

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Cnbc.com which released: "J&J gets second upgrade this week as Jefferies calls it a "dividend machine" on October 11, 2017, also Seekingalpha.com with their article: "Johnson & Johnson files United States marketing application for prostate cancer med ..." published on October 11, 2017, Seekingalpha.com published: "Johnson & Johnson Needs To Do This With The Consumer Segment" on October 12, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Share